Comparing continuous glucose monitoring to finger stick testing for healing diabetic foot ulcers.
Randomized controlled trial of continuous glucose monitoring compared to point of care glucose testing following hospital discharge on 12-week diabetic foot ulcer healing rates
['FUNDING_R03'] · EMORY UNIVERSITY · NIH-10727731
This study is looking at whether using a continuous glucose monitor (CGM) helps people with diabetic foot ulcers heal better after leaving the hospital compared to the usual finger stick testing, and it’s for patients who have just been treated for these ulcers.
Quick facts
| Phase | ['FUNDING_R03'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | EMORY UNIVERSITY (nih funded) |
| Locations | 1 site (ATLANTA, UNITED STATES) |
| Trial ID | NIH-10727731 on ClinicalTrials.gov |
What this research studies
This research investigates the effectiveness of continuous glucose monitoring (CGM) versus traditional finger stick testing in improving healing rates of diabetic foot ulcers (DFUs) after hospital discharge. The study will enroll 96 patients who have been hospitalized for DFUs and will randomly assign them to either CGM or standard care for a 12-week period. By using real-time CGM, patients can monitor their blood sugar levels more easily, which may lead to better management of their diabetes and improved healing outcomes. The study aims to provide insights into how better glucose control can impact the healing of DFUs, a serious complication of diabetes.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults with diabetic foot ulcers who have been recently hospitalized.
Not a fit: Patients who do not have diabetic foot ulcers or those who are not recently discharged from the hospital may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved healing rates for diabetic foot ulcers, reducing the risk of hospitalization and limb loss.
How similar studies have performed: Previous research has shown that continuous glucose monitoring can improve glycemic control in diabetes, but its specific impact on diabetic foot ulcers has not been extensively studied.
Where this research is happening
ATLANTA, UNITED STATES
- EMORY UNIVERSITY — ATLANTA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: FAYFMAN, MAYA — EMORY UNIVERSITY
- Study coordinator: FAYFMAN, MAYA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancers